XT
ONCY

XTX Topco’s Oncolytics Biotech ONCY Stock Holding History

XTX Topco’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
260,903
+151,145
+138% +$140K ﹤0.01% 3081
2026
Q1 		$93.2K Buy
109,758
+31,097
+40% +$30.9K ﹤0.01% 3127
2025
Q4 		$68.8K Buy
+78,661
New +$85K ﹤0.01% 2749
2025
Q3 		– Sell
-12,631
Closed -$9.76K – 3066
2025
Q2 		$9.76K Buy
+12,631
New +$6.69K ﹤0.01% 2234

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco's ONCY Position: Q2 2026 in Review

XTX Topco increased its Oncolytics Biotech (ONCY) stake by 138% in Q2 2026, buying an estimated $140K and bringing the position to 260,903 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #3081.

XTX Topco first reported a position in ONCY in Q2 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • XTX Topco held 260,903 shares of Oncolytics Biotech worth $248K as of Q2 2026.
  • XTX Topco bought 151,145 Oncolytics Biotech shares in Q2 2026, an estimated $140K.
  • Oncolytics Biotech made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3081 holding.
  • XTX Topco first reported a position in Oncolytics Biotech in Q2 2025 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.